Live feed19:30:00·49dPRReleasevia QuantisnowCanada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseByQuantisnow·Wall Street's wire, on your screen.BIIB· Biogen Inc.Health Care
